The Discounted Cash Flow (DCF) valuation of Maravai LifeSciences Holdings Inc (MRVI) is (13.54) USD. With the latest stock price at 3.37 USD, the upside of Maravai LifeSciences Holdings Inc based on DCF is -501.7%.
Based on the latest price of 3.37 USD and our DCF valuation, Maravai LifeSciences Holdings Inc (MRVI) is a sell. selling MRVI stocks now will result in a potential gain of 501.7%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 8.9% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (24.17) - (9.63) | (13.54) |
| Upside | -817.2% - -385.8% | -501.7% |